z-logo
open-access-imgOpen Access
Romosozumab for the treatment of osteoporosis in women: Efficacy, safety, and cardiovascular risk
Author(s) -
Sian Yik Lim
Publication year - 2022
Publication title -
women s health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.363
H-Index - 39
eISSN - 1745-5065
pISSN - 1745-5057
DOI - 10.1177/17455057221125577
Subject(s) - sclerostin , medicine , osteoporosis , wnt signaling pathway , signal transduction , chemistry , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom